Exelixis Affirms FY2026 Sales Guidance of $2.525B-$2.625B vs $2.583B Est

Benzinga Newsdesk www.benzinga.com Negative 77.7%

Neg 77.7% Neu 0% Pos 0%

Exelixis (NASDAQ:EXEL) affirms FY2026 sales outlook from $2.525 billion-$2.625 billion to $2.525 billion-$2.625 billion vs $2.583 billion estimate.